Cipla Tadacip, Purity : 99 %

Tadacip contains Tadalafil, a potent and long-acting phosphodiesterase type 5 (PDE5) inhibitor widely used to treat erectile dysfunction (ED) in adult men. Manufactured by Cipla Ltd., Tadacip offers an effective alternative to branded tadalafil products, providing reliable and sustained therapeutic benefits.

Each film-coated tablet contains 20 mg of Tadalafil, which works by relaxing smooth muscles and increasing blood flow to the penile tissue during sexual stimulation. Tadacip’s longer half-life allows for an extended window of efficacy, up to 36 hours, earning it the nickname \\\"the weekend pill.\\\"

Product Details:

\r
• \r

  Active Ingredient: Tadalafil 20 mg

  \r
\r
• \r

  Dosage Form: Oral film-coated tablets

  \r
\r
• \r

  Packaging: Blister packs of 4, 10, or 20 tablets; bulk packaging available

  \r
\r
• \r

  Shelf Life: 24 months

  \r
\r
• \r

  Manufacturer: Cipla Ltd.

  \r
\r
• \r

  Manufacturing Standards: WHO-GMP certified facilities

  \r
\r

Key Features:

\r
• \r

  Long-lasting effect, up to 36 hours

  \r
\r
• \r

  Rapid onset, typically within 30–60 minutes

  \r
\r
• \r

  Suitable for prescription distribution through pharmacies and telehealth services

  \r
\r
• \r

  Manufactured under stringent quality control and certification

  \r
\r

Indications:

\r
• \r

  Treatment of erectile dysfunction in adult males

  \r
\r
• \r

  Also prescribed for benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension in some markets (consult local regulations)

  \r
\r

Quality Assurance & Compliance:

\r
• \r

  Supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and batch release certificates

  \r
\r
• \r

  Prescription-only medication; distribution subject to regulatory compliance

  \r
\r
• \r

  Export-ready packaging with multilingual patient information inserts available

  \r
\r